Skip to search formSkip to main contentSkip to account menu

tecadenoson

Known as: N-(3-tetrahydrofuranyl)-6-aminopurine riboside 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Termination of Paroxysmal Supraventricular Tachycardia by Tecadenoson (CVT-510), a Novel A1-Adenosine Receptor Agonist Eric N… 
2015
2015
During atrial fibrillation (AF), conventional electrophysiological techniques for assessment of refractory period or conduction… 
Review
2008
Review
2008
Background: The challenges in developing any A1 adenosine receptor (A1-AdoR) agonist involve having the desired effect on target… 
2005
2005
Background—Tecadenoson is a potent selective A1-adenosine receptor agonist with a dose-dependent negative dromotropic effect on… 
2005
2005
Tecadenoson is a novel selective A1 adenosine receptor agonist that is currently being evaluated for the conversion of paroxysmal… 
2003
2003
Introduction: Tecadenoson, a selective A1 adenosine derivative,prolongs AV nodal conduction without A2-mediated reductions in BP… 
2003
2003
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2002
2002
Adenosine has been shown to be a clinically effective antiarrhythmic agent. However, because it acts on all 4 adenosine cell…